Insider trades
Ingrid Delaet, Chief Officer of Neurocrine Biosciences NBIX, has filed 0 purchases and 31 sales on the open market. Over the past 12 months that comes to a net sale of $354.3K. The latest trade was on 05/29.
Ingrid Delaet
Chief Regulatory Officer
- Company
- Neurocrine Biosciences NBIX
- First filing
- 23/02/15
- Trades
- 101 trades
- Buys / sales
- 0 / 31
- 12-month net buying
- −$354.3K
- Last trade
- 05/29
Trading activity
Transactions
| Trade type | |||||||
|---|---|---|---|---|---|---|---|
| Open-market sale10b5-1 plan | 05/29 | 06/02 | 2,261 sh | $156.71 | $354,321.31 | −12.2% | |
| Open-market sale10b5-1 plan | 25/07/10 | 25/07/11 | 457 sh | $135.00 | $61,695 | −8.8% | |
NBIX | Open-market sale10b5-1 plan | 25/02/13 | 25/02/14 | 1,471 sh2 trades | $116.71avg. | $171,673.64 | −23.7% |
NBIX | Open-market sale10b5-1 plan | 25/01/31–25/02/03 | 25/02/04 | 1,045 sh2 trades | $150.81avg. | $157,594.77 | −23.3% |
| Open-market sale10b5-1 plan | 24/12/31 | 25/01/03 | 272 sh | $138.10 | $37,563.2 | −9.8% | |
| Open-market sale10b5-1 plan | 24/12/17 | 24/12/19 | 1,091 sh | $135.00 | $147,285 | −30.3% | |
NBIX | Open-market sale10b5-1 plan | 24/08/13 | 24/08/15 | 7,143 sh2 trades | $150.10avg. | $1,072,173.59 | −74.0% |
| Open-market sale10b5-1 plan | 24/08/06 | 24/08/08 | 273 sh | $147.70 | $40,322.1 | −4.0% | |
NBIX | Open-market sale10b5-1 plan | 24/07/16 | 24/07/18 | 2,857 sh3 trades | $150.03avg. | $428,626 | −30.2% |
| Open-market sale10b5-1 plan | 24/07/01 | 24/07/02 | 272 sh | $138.11 | $37,565.92 | −3.5% | |
| Open-market sale10b5-1 plan | 24/05/31 | 24/06/04 | 273 sh | $136.55 | $37,278.15 | −3.5% | |
| Open-market sale10b5-1 plan | 24/05/06 | 24/05/08 | 273 sh | $140.55 | $38,370.15 | −3.5% | |
| Open-market sale10b5-1 plan | 24/04/01 | 24/04/03 | 272 sh | $137.30 | $37,345.6 | −3.5% | |
| Open-market sale10b5-1 plan | 24/03/21 | 24/03/25 | 5,000 sh | $145.06 | $725,300 | −40.0% | |
| Open-market sale10b5-1 plan | 24/03/13 | 24/03/15 | 3,000 sh | $140.14 | $420,420 | −28.6% | |
NBIX | Open-market sale10b5-1 plan | 24/03/08–24/03/11 | 24/03/12 | 2,000 sh2 trades | $140.03avg. | $280,054 | −21.0% |
NBIX | Open-market sale10b5-1 plan | 24/02/28–24/02/29 | 24/02/29 | 6,817 sh4 trades | $135.34avg. | $922,628.23 | −47.6% |
| Open-market sale10b5-1 plan | 24/02/13 | 24/02/15 | 716 sh | $133.03 | $95,249.48 | −8.7% | |
NBIX | Open-market sale10b5-1 plan | 24/01/31–24/02/01 | 24/02/02 | 1,045 sh2 trades | $140.65avg. | $146,975.39 | −13.2% |
| Open-market sale10b5-1 plan | 23/08/28 | 23/08/30 | 1,431 sh | $107.52 | $153,861.12 | −19.4% |